Ignite Creation Date:
2025-12-24 @ 8:02 PM
Ignite Modification Date:
2026-01-06 @ 1:03 PM
Study NCT ID:
NCT05872204
Status:
RECRUITING
Last Update Posted:
2025-03-19
First Post:
2023-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
Sponsor:
Universitaire Ziekenhuizen KU Leuven
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
S66468
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None